Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Researchers at the University of Pittsburgh School of Medicine in the US have reported encouraging results from initial tests of a Covid-19 vaccine candidate, PittCoVacc, delivered using a fingertip-sized patch in mice.
In the animals, the candidate was able to generate antibodies specific to SARS-CoV-2 at levels that might be enough to neutralise the virus, noted the researchers.
The findings have been detailed in eBioMedicine published by The Lancet journal. Pitt School of Medicine surgery associate professor Andrea Gambotto said: “We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014.